Role of vascular nitric oxide in physiological and pathological conditions

Pharmacology and Therapeutics

Volumn 75, Issue 2, 1997, Pages 111-134

  Marín, Jesús ^a   Rodríguez Martínez, M Angeles ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Atherosclerosis; Diabetes mellitus; Heart failure; Hypertension; L arginine; Nitric oxide

Indexed keywords

AMYL NITRITE; ARGININE; ENDOTHELIUM DERIVED RELAXING FACTOR; LINSIDOMINE; MOLSIDOMINE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITROSO DERIVATIVE; ORGANIC NITRATE; VASODILATOR AGENT;

ATHEROSCLEROSIS; DIABETES MELLITUS; ESSENTIAL HYPERTENSION; HISTOCHEMISTRY; HUMAN; HYPOTENSION; ISCHEMIA; MIGRAINE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEPSIS; STROKE; UNSTABLE ANGINA PECTORIS; VASCULAR ENDOTHELIUM;

ANIMALS; ARGININE; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 0343765700     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(97)00051-X     Document Type: Review

References (349)

1. Abiru, T., Watanabe, Y., Kamata, K., Miyata, N. and Kasuya, Y. (1990) Decrease in endothelium-dependent relaxation and levels of cyclic nucleotides in aorta from rabbits with alloxaninduced diabetes. Res. Commun. Chem. Pathol. Pharmacol. 68: 13-25.
2. Akopov, S., Sercombe, R. and Seylaz, J. (1996) Cerebrovascular reactivity: role of endothelium/platelet/leukocyte interactions. Cerebrovasc. Brain Metab. Rev. 8: 11-94.
3. Alonso, M J., Salaíces, M., Sánchez-Ferrer, C. F. and Marín, J. (1992) Predominant role for nitric oxide in the relaxations induced by acetylcholine in cat cerebral arteries. J. Pharmacol. Exp. Ther. 261: 12-21.
4. Andersson, D. K. ( 1976) Cell potential and the sodium-potassium pump in vascular smooth muscle. Proc. Fed. Am. Exp. Biol. 35: 1294-1297.
5. Angus, J. A. and Cocks, T. M. (1989) Endothelium-derived relaxing factor. Pharmacol. Ther. 41: 303-351.
6. Arnal, J. F., Battle, T., Ménard, J. and Michel, J. B. (1993) The vasodilatory effect of endogenous nitric oxide is a major counter-regulatory mechanism in the spontaneously hypertensive rat. J. Hypertens. 11: 945-950.
7. Arribas, S., Marín, J., Ponte, A., Balfagón, G. and. Salaíces, M. (1994) Norepinephrine-induced relaxations in rat aortae mediated by endothelial β-adrenoceptors: impairment by ageing and hypertension. J. Pharmacol. Exp. Ther. 270: 520-527.
8. Assender, J. W., Southgate, K. M. and Newby, A. C. (1991) Does nitric oxide inhibit smooth muscle proliferation? J. Cardiovasc. Pharmacol. 17 (Suppl. 3): S104-S107.
9. Assreuy, J., Cunha, F. Q., Liew, F. Y. and Moncada, S. (1993) Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br. J. Pharmacol. 108: 833-337.
10. Auch-Schwelk, W. and Vanhoutte, P. M. (1991) Endotheliumderived contracting factor released by serotonin in the aorta of the spontaneously hypertensive rat. Am. J. Hypertens. 4: 769-772.
11. 2-receptor antagonists inhibit endotheliumdependent contractions. Hypertension 15: 699-703.
12. Azuma, H., Sato, J., Hamasaki, H., Sugimoto, A., Isotani, E. and Obayashi, S. ( 1995) Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L-arginine in regenerated endothelial cells. Br. J. Pharmacol. 115: 1001-1004.
13. Bachmann, S., Peters, J., Engler, E., Ganten, D. and Mullins, J. J. (1992) Transgenic rats carrying the mouse renin gene-morphological characterization of a low-renin hypertension. Kidney Int. 41:24-36.
14. Balligand, J., Kelly, R. A.. Marsden, P. A., Smith, T. W. and Michel, T. ( 1993) Control of cardiac muscle cell function by an endogenous nitric oxide signalling system. Proc. Natl. Acad. Sci. USA 90: 347-351.
15. Bar, R. S. (1992) Vascular endothelium and diabetes mellitus. In: Endothelial Cell Dysfunctions, pp. 363-381, Simionescu, N. and Simionescu, M. (eds.) Plenum, New York.
16. Bauer, J. A., Booth, B. P. and Fung, H. L (1995) Nitric oxide donors: biochemical pharmacology and therapeutics. Adv. Pharmacol. 34: 361-381.
17. Baumgartner-Parzer, S. M., Wagner, L., Pettermann, M., Grillari, J., Gessl, A. and Waldhäusl, W. (1995) High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes 44: 1323-1327.
18. Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A. and Freeman, B. A. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87: 1620-1624.
19. Bevan, R. D. (1984) Trophic effects of peripheral adrenergic nerves on vascular structure. Hypertension 6 (Suppl. III): III19-III26.
20. Billiard, T. R., Curran, R. D., Stuehr, D. J., Stadler, J., Simmons, R. L. and Murray, S. A. (1990) Inducible cytosolic enzyme activity for the production of nitrogen oxides from L-arginine in hepatocytes. Biochem. Biophys. Res. Commun. 168: 1034-1040.
21. i in vascular smooth muscle by inhibition of the calcium current. Cell Calcium 15: 122-131.
22. Bockman, C. S., Jeffries, W. B., Pettinger, W. A. and Abel, P. W. (1992) Enhanced release of endothelium-derived relaxing factor in mineralocorticoid hypertension. Hypertension 20: 304-313.
23. Bogle, R. G., Baydoun, A. R., Pearson, J. D. and Mann, G. E. (1996) Regulation of L-arginine transport and nitric oxide release in superfused porcine aortic endothelial cells. J. Physiol. 490: 229-241.
24. Bolger, G. T., Liard, F., Jodoin, A. and Jaramillo, J. (1991) Vascular reactivity, tissue levels, and binding sites for endothelin: a comparison in the spontaneously hypertensive and Wistar-Kyoto rats. Can. J. Physiol. Pharmacol. 69: 406-413.
25. Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Feyn, A. M., Knaus, W. A., Schein, R. M. and Sibbald, W. J. ( 1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101: 1644-1655.
26. Bonnardeaux, A., Nadaud, S., Charru, A., Jeunemaitre, X., Corvol, P. and Soubrier F. (1995) Lack of evidence for linkage of the endothelial cell nitric oxide synthase gene to essential hypertension. Circulation 91: 96-102.
27. Bonner, F. T. ( 1996) Nitric oxide gas. In: Methods in Enzymology, Vol. 268, pp. 50-57, Packer, L. (ed.) Academic Press, San Diego.
28. Borhani, N. O. (1988) Isolated systolic hypertension in the elderly. J. Hypertens. 6: S15-S19.
29. Bossaller, C., Habib, G. B., Yamamoto, H., Williams, C., Wells, S. and Henry, P. D. (1987) Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J. Clin. Invest. 79: 170-174.
30. 2 to nitric oxide and citrulline. Biochem. Biophys. Res. Commun. 187: 880-886.
31. Bredt, D. S. and Snyder, S. H. ( 1990) Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 87: 682-685.
32. Bredt, D. S., Hwang, P. M., Glatt, C. E., Lowenstein, C., Reed, R. and Snyder, S. H. (1991) Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 rednctase. Nature 351: 714-718.
33. Bredt, D. S., Ferris, C. D. and Snyder, S. H. (1992) Nitric oxide synthase regulatory sites: phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium calmodulin protein kinase; identification of flavin and calmodulin binding sites. J. Biol. Chem. 267: 10976-10981.
34. Bucala, R., Tracey, K. J. and Cerami, A. (1991) Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J. Clin. Invest. 87: 432-438.
35. Busconi, L. and Michel, T. (1993) Endothelial nitric oxide synthase: N-terminal myristoylation determines subcellular localization. J. Biol. Chem. 268: 8410-8413.
36. Casino, P. R., Kilcoyne, C. M., Quyyumi, A. A., Hoeg, J. M. and Panza, J. A. (1993) The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 88: 2541-2547.
37. Chabaud, F., Danna, M. and Bény, J. L. (1994) A vascular smooth muscles nitric oxide relaxation by a mechanism distinct of calcium changes. Life Sci. 54: 1449-1458.
38. Chen, Y. F. and Meng, Q. C. (1991) Sexual dimorphism of blood pressure in spontaneously hypertensive rats is androgen dependent. Life Sci. 48: 748-759.
39. Cho, H. J., Xie, Q. W., Calaycay, J., Mumford, R. A., Swiderek, K. M.. Lee, T. D. and Nathan, C. (1992) Calmodulin is a subunit of nitric oxide synthasc from macrophages. J. Exp. Med. 176: 599-604.
40. Clozel, M., Kuhn, H., Hefti, F. and Baumgartner, H. R. (1991) Endothelial dysfunction and subendothelial monocyte macrophages in hypertension: effect of angiotensin converting enzyme inhibition. Hypertension 18: 132-141.
41. Cobb, J. P. and Danner, R. L. (1996) Nitric oxide and septic shock. JAMA 275: 1192-1196.
42. Cohen, R. A. (1995) The role of nitric oxide and other endothclium-derived vasoactivo substances in vascular disease. Prog. Cardiovasc. Dis. 38: 105-128.
43. Cohen, R. A. and Tesfamariam, B. (1992) Diabetes mellitus and the vascular endothelium. In: Hyperglycemia, Diabetes and Vascular Disease, pp. 44-49, Ruderman, N. (ed.) Oxford University Press, New York.
44. Cohen, R. A., Zitnay, K. M., Haudenschild, C. C. and Cunningham, L. D. (1988) Loss ot selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Circ. Res. 63: 903-910.
45. Colden-Stanfield, M., Schilling, W. P., Ritchie, A. K.. Eskin, S.G., Navarro, L. T. and Kunze, D. L. (1987) Bradykinininduced increases in cytosolic calcium and ionic currents in cultured bovine aortic endothelial cells. Circ. Res 61: 632-640.
46. Collins, P., Griffith, T. M., Henderson, A. H. and Lewis, M. J. (1986) Endothelium-derived relaxing factor alters calcium fluxes in rabbit aorta: a cyclic guanosine monophosphate-mediated effect.J. Physiol. (Lond.) 381: 427-437.
47. Cooke, J. P., Singer, A. H., Tsao, P. S., Zera, P., Rowan, R. A. and Billingham, M. E. (1992) Antiatherogenic eflects of L-arginine in the hypercholesterolemic rabbits. J. Clin. Invest. 90: 1168-1172.
48. Cornwell, T. L., Pryzwansky, K. B., Wyatt, T. A. and Lincoln, T. M. ( 1991 ) Regulation ot sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells. Mol Pharmacol. 40: 923-931.
49. Creager, M. A., Gallagher, S. J., Girerd, X. J., Coleman. S. M., Dzau, V. J. and Cooke, J. P. (1992) L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic human. J. Clin. Invest. 90: 1248-1253.
50. Cunningham, L. D., Brecher, P. and Cohen, R. A. (1992) PDGF receptors on macrovascular endothelial cells mediate relaxations via nitric oxide in rat aorta. J. Clin. Invest. 89: 878-882.
51. Curran, R. D., Billiar, T. R., Stuehr, D. J., Hofmann, K. and Simmons, R. L. (1989) Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells.J. Exp. Med. 170: 1769-1774.
52. Dalkara, T., Yoshida, T., Irikura, K. and Moskowitz, M. A. (1994) Dual role of nitric oxide in focal cerebral ischemia. Neuropharmacology 33: 1447-1452.
53. Davada, R. K., Chandler, L. J. and Guzman, N. J. (1994) Protein kinase C modulates receptor-independent activation of endothelial nitric oxide synthase. Eur. J. Pharmacol. 266: 237-244.
54. Dawson, T. M., Steiner, S. P., Dawson, V. L., Dinerman, J. L., Uhl, G. R. and Snyder, S. H. (1993) Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc. Natl. Acad. Sci. USA 90: 9808-9812.
55. De Beider, A. J., Radomski, M. W., Why, H. J. F., Richardson, P. J., Bucknall, C. A., Salas, E., Martin, J. F. and Moncada, S. (1993) Nitric oxide synthase activities in human myocardium. Lancet 341: 84-85.
56. De Beider, A. J., Lees, C., Martin, J., Moncada, S. and Campbell, S. (1995) Treatment of HELLP syndrome with nitric oxide donor. Lancet 345: 124-125.
57. Deisher, T. A., Mankani, S. and Hoffman, B. B. (1989) Role of cyclic AMP-dependent protein kinase in the diminished beta adrenergic responsiveness of vascular smooth muscle with increasing age. J. Pharmacol. Exp. Ther. 249: 812-819.
58. Dinerman, J. L. and Mehta, J. L. (1990) Endothelial, platelet and leukocyte interactions in ischemic heart disease: insights into potential mechanisms and their clinical relevance. J. Am. Coll. Cardiol. 16: 207-222.
59. Dinerman, J. L., Dawson, T. M., Schell, M. J., Snowman, A. and Snyder, S. H. ( 1994) Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proc. Natl. Acad. Sci. USA 91: 4214-4218.
60. Doherty, A. M. (1992) Endothelin: a new challenge. J. Med. Chem. 35: 1493-1508.
61. Doherty, A. M. (1995) The development of endothelin antagonists to moderate cardiovascular function. In: Hypertension: Pathophysiology, Diagnosis, and Management, 2nd edn., pp. 3115-3136, Laragh, J. H. and Brenner, B. M. (eds.) Raven Press, New York.
62. Dohi, Y., Thiel, M., Bühler, F. R. and Lüscher, T. F. (1990) Activation of the endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension. Hypertension 16: 170-179.
63. Dominiczak, A. F. and Bohr, D. F. (1995) Nitric oxide and its putative role in hypertension. Am. Heart Assoc. 25: 1202-1211.
64. Dubin, D., Prat, R. E., Cooke, J. P. and Dzau, V. J. (1989) Endothelin, a potent vasoconstrictor, is a vascular smooth muscle mitogen. J. Vase. Med. Biol. 1: 150-154.
65. Dun, N. J., Dun, S. L., Förstermann, U. and Tseng, L. F. (1992) Nitric oxide synthase immunoreactivity in rat spinal cord. Neurosci. Lett. 147: 217-220.
66. Dun, N. J., Dun, S. L, Wu, S. Y. and Förstermann, U. (1993) Nitric oxide synthase immunoreactivity in rat superior cervical ganglia and adrenal glands. Neurosci. Lett. 158: 51-54.
67. Egashira, K., Inou, T., Hirooka, Y., Yamada, A., Maruoka, Y., Hai. H., Sugimachi, M., Suzuki, S. and Takeshita, A. (1993) Impaired coronary artery blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J. Clin. Invest. 91: 29-37.
68. Ely, D. L. and Turner, M. E. (1990) Hypertension in the spontaneously hypertensive rat is linked to the Y chromosome. Hypertension 16: 277-281.
69. Farhat, M. Y., Chen, M. F., Bhatti, T., Iqbal, A., Cathapermal, S. and Ramwell, P. W. (1993) Protection by oestradiol against the development of cardiovascular changes associated with monocrotaline pulmonari hypertension in rats. Br. J. Pharmacol. 110: 719-723.
70. Farrell, A. J. and Blake, D. R. (1996) Nitric oxide. Ann. Rheum. Dis. 55: 7-20.
71. Feelisch, M. (1993) Biotransformation to nitric oxide of organic nitrates in comparison to other nitrovasodilators. Eur. Heart J. 14: 123-132.
72. Feigl, E. O. (1988) EDRF: a protective factor? Nature 331: 490-491.
73. Finkel, M. S., Oddis, C. V., Jacob, T. D., Watkins, S. C., Hattler, B. G. and Simmons, R. L. (1992) Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387-389.
74. Fiscus, R. R. ( 1988) Molecular mechanisms of endothelium-mediated vasodilation. Semin. Thromb. Hemostasis. 14 (Suppl.): 12-22.
75. Fitzgerald, G. A., Brash, A. R., Falardeau, P. and Oates, J. A. (1981) Estimated rate of prostacyclin secretion into the circulation of normal man. J. Clin. Invest. 68: 1272-1275.
76. Flavaham, N. A., Shimokawa, H. and Vanhoutte, P. M. (1991) Inhibition of endothelium-dependent relaxations by phorbol myristate acetate in canine coronary arteries: role of a pertussis toxin-sensitive G-protein. J. Pharmacol. Exp. Ther. 256: 50-55.
77. Fleming, I. and Busse, R. (1995) Control and consequences of endorhelial nitric oxide formation. Adv. Pharmacol. 34: 187-206.
78. Folkow, B. and Svanborg, A. (1993) Physiology of vascular aging. Physiol. Rev. 73: 725-764.
79. Förstemann, U., Gorsky, L. D., Pollock, J. S., Ishii, K., Schmidt, H. H., Heller, M. and Murad, F. (1990) Hormone-induced biosynthesis of endothelium-derived relaxing factor/nitric oxidelike material in N1E-115 neuroblastoma cells requires calcium and calmodulin. Mol. Pharmacol. 38: 7-13.
80. Förstermann, U., Pollok, J. S., Schmidt, H. H., Heller, M. and Murad, F. (1991) Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA 88: 1788-1792.
81. Furchgott, R. F. (1984) The role of the endothelium in the responses of vascular smooth muscle to drugs. Annu. Rev. Pharmacul. Toxicol. 24: 175-197.
82. Furchgott, R. F. (1988) Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable inhibitory factor from bovine retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. In: Vasodilatation, Vol. IV, pp. 401-414, Vanhoutte, P. M. (ed.) Raven Press, New York.
83. Furchgott, R. F. and Zawadzki, J. (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 228: 373-376.
84. Galle, J, Bauersachs, J., Bassenge, E. and Busse, R. (1993) Arterial size determines the enhancement of contractile responses after supression of endothelium-derived relaxing factor formation. Pflügers Arch. 422: 564-569.
85. Ganten, U., Schröder, G., Witt, M., Zimmerman, F., Ganten, D. and Stock, G. (1989) Sexual dimorphism of blood pressure in spontaneously hypertensive rats: effects of anti-androgen treatment. Hypertension 7: 721-726.
86. Gibbons, G. H. and Dzau, V. J. (1990) Angiotensin converting enzyme: inhibition and vascular hypertrophy in hypertension. Cardiovasc. Drugs Ther. 4: 237-242.
87. Gisclard, V., Flavaham, N. A. and Vanhoutte, P. M. (1987) Alpha adrenergic responses of blood vessels of rabbits after ovariectomy and administration of 17-β-estradiol. J. Pharmacol. Exp. Ther. 240: 466-470.
88. Glauser, M. P., Zanetti, G., Baumgartner, J.-D. and Cohen, J. (1991) Septic shock: pathogenesis. Lancet 338: 732-736.
89. Godfraind, T. (1986) EDRF and cyclic GMP control gating of receptor-operated calcium channels in vascular smooth muscle. Eur. J. Pharmacol. 126: 341-343.
90. Govantes, C., Rodríguez-Martínez, M. A. and Marín, J. (1996) Vasodilator effect and tolerance induced by the nitrocompound SIN-1 in rabbit femoral artery. Methods Find. Exp. Clin. Pharmacol. 18:387-395.
91. Greenberg, S., Diecke, F. P. J. and Tanaka, T. P. (1986) Species and vascular bed responses of veins and arteries to endothelial derived relaxing factor in dog and pig. Drug Dev. Res. 7: 299-309.
92. Griffith, T. M., Edwards, D. H., Newby, A. C., Lewis, M. J. and Henderson, A. H. (1986) Production of endothelium derived relaxant factor is dependent on oxidative phosphorylation and extracellular calcium. Cardiovasc. Res. 20: 7-12.
93. Griffith, T. M., Edwards, D. H., Davies, R. L, Harrison, T. J. and Evans, K. T. ( 1987) EDRF coordinates the behavior of vascular resistance vessels. Nature 329: 442-445.
94. Griscavage, J. M., Rogers, N. E., Sherman, M. P. and Ignarro, L. J. (1993) Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide. J. Immunol. 151: 6329-6337.
95. + ATPase activity in rabbit aorta by hyperglycemia: possible role of endothelium derived nitric oxide. J. Clin. Invest. 90: 727-732.
96. +-ATPase activity by nitric oxide: a cGMP-independent effect. Am. J. Physiol. 266: H2146-H2151.
97. Halkin, A., Benjamin, N., Doktor, H. S., Todd, S. D., Viberti, G. and Ritter, J. M. (1991) Vascular responsiveness and cation exchange in insulin-dependent diabetes. Clin. Sci. 81: 223-232.
98. Hanahan, D. J. (1986) Platelet-activating factor: a biologically active phosphoglyceride. Annu. Rev. Biochem. 55: 483-509.
99. Hare, J. and Colucci, W. S. (1995) Role of nitric oxide in the reg-ulation of myocardial function. Prog. Cardiovasc. Res. 28: 155-166.
100. Harris, E. L., Grigor, M. R. and Millar, J. A. (1990) Differences in mitogenic responses to angiotensin II, calf serum and phorbol ester in vascular smooth muscle cells from two strains of genetically hypertensive rat. Biochem. Biophys. Res. Commun. 170: 1249-1255.
101. Harrison, D. G., Armstrong, M. L., Freiman, P. C. and Heistad, D. D. (1987) Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J. Clin. Invest. 80: 1808-1811.
102. Hart, M. N., Heistad, D. D. and Brody, M. J. (1980) Effect of chronic hypertension and sympathetic denervation on wall/ lumen ratio of cerebral vessels. Hypertension 2: 419-423.
103. Hasan, K., Heesen, B. J., Corbett, J. A., McDaniel, M. L, Chang, K., Allison, W., Wolffenbuttel, B. H., Williamson, J. R. and Tilton, R. G. (1993) Inhibition of nitric oxide formation by guanidines. Eur. J. Pharmacol. 249: 101-106.
104. Hassall, C. J., Saffrey, M. J., Belai, A., Hoyle, C. H., Moules, E. W., Moss, J., Schmidt, H. H., Murad, F., Förstermann, U. and Burnstock, G. (1992) Nitric oxide synthase immunoreactivity and NADPH-diaphorase activity in a subpopulation of intrinsic neurones of the guinea-pig heart. Neurosci. Lett. 143: 65-68.
105. Hathaway, D. R., Konicki, M. V. and Coolican, S. A. (1985) Phosphorylation of myosin light chain kinase from vascular smooth muscle by cAMP and cGMP dependent protein kinases. J. Mol. Cell Cardiol. 17: 841-850.
106. Hattori, Y., Kawaski, H., Abe, K. and Kanno, M. (1991) Superoxide dismutase recovers altered endothelium-dependent relaxations in diabetic rat aorta. Am. J. Physiol. 261: H1086-H1094.
107. Haudenschild, C. C., Prescott, M. F. and Chobanian, A. V. (1979) Effects of hypertension and its reversal on aortic intima lesions of the rat. Hypertension 2: 33-44.
108. Hecker, M., Lückhoff, A. and Busse, R. (1993) Modulation of endothelial autacoid release by protein kinase C: feed-back inhibition or non-specific attenuation of receptor-dependent cell activation. J. Cell. Physiol. 156: 571-578.
109. Hevel, J. M., White, K. A. and Marletta, M. A. (1991) Purification of the inducible murine macrophage nitric oxide synthase. J. Biol. Chem. 266: 22789-22791.
110. Hirata, M., Kohse, K. P., Chang, C.-H., Ikebe, T. and Murad, F. (1990) Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells. J. Biol. Chem. 265: 1268-1273.
111. Hishikawa, K., Nakaki, T., Suzuki, H., Kato, R. and Saruta, T. (1992a) L-Arginine as an antihypertensive agent. J. Cardiovasc. Pharmacol. 20: S196-5197.
112. Hishikawa, K., Nakaki, T., Tsuda, M., Esumi, H., Ohshima, H., Suzuki, H., Saruta, T. and Kato, R. (1992b) Effects of systemic L-arginine administration on hemodynamics and nitric oxide release in man. Jpn. Heart J. 33: 41-48.
113. Hishikawa, K., Nakaki, T., Suzuki, H., Kato, R. and Saruta, T. (1993) Role of L-arginine-nitric oxide pathway in hypertension. J. Hypertens. 11: 639-645.
114. Hongo, K., Nakagomi, T., Kassell, N. F., Sasaki, T., Lehman, M., Vollmer, D. G., Tsukahara, T., Ogawa, H. and Torner, J. (1988) Effects of aging and hypertension on endotheliumdependent vascular relaxation in rat carotid artery. Stroke 19: 892-897.
115. Huang, P. L. and Fishman, M. C. (1996) Genetic analysis of nitric oxide synthase isoforms: targeted mutation in mice. J. Mol. Med. 74: 415-421.
116. Huang, Z., Huang, P. L., Panahian, N., Dalkara, T., Fishman, M. C. and Moskowitz, M. A. (1994) Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265: 1883-1885.
117. Huttner, I. and Gabbiani, G. (1983) Vascular endothelium in hypertension. In: Hypertension, pp. 473-488, Genest, O., Kuchel, J., Hamet, P. and Cantin, M. (eds.) McGraw-Hill, New York.
118. Iams, S. G. and Wexler, B. C. (1977) Retardation in the development of spontaneous hypertension in SH rats by gonadectomy. J. Lab. Clin. Med. 90: 997-1003.
119. Iams, S. G. and Wexler, B. C. (1979) Inhibition of die development of spontaneous hypertension in SH rats by gonadectomy or estradiol. J. Lab. Clin. Med. 94: 608-616.
120. Ignarro, L. J. (1989a) Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ. Res. 65: 1-21.
121. Ignarro, L. J. (1989b) Endothelium-derived nitric oxide: actions and properties. FASEB J. 3: 31-36.
122. Ignarro, L. J. (1992) Haem-dependent activation of cytosolic guanylate cyclase by nitric oxide: a widespread signal transduction mechanism. Biochem. Soc. Trans. 20: 465-469.
123. Ignarro, L. J. and Kadowitz, P. J. (1985) The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu. Rev. Pharmacol. Toxicol. 25: 171-191.
124. Ignarro, L. J., Lippton, H., Edwards, J. C., Baricos, W. H., Hyman, A. L., Kadowitz, P. J. and Gruetter, C. A. (1981) Mechanisms of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J. Phannacol. Exp. Ther. 218: 739-741.
125. Ignarro, L. J., Degnan, J. N., Baricos, W. H., Kadowitz, P. J. and Wolin, M. S. (1982) Activation of purified guanylate cyclase by nitric oxide requires heme: comparison of heme-deficient, heme-reconstitued and heme-containing forms of soluble enzyme from bovine lung. Biochim. Biophys. Acta 718: 49-59.
126. 2+/calmodulin-dependent multifunctional protein kinase. J. Biol. Chem. 265: 8975-8978.
127. ω-Hydroxyagmatine: a novel substance causing enciothelium-dependent vasorelaxation. Biochem. Biophys. Res. Commun. 214: 145-151.
128. 2 as an endothelium-derived contracting factor and its interaction with endothelium-derived nitric oxide. J. Hypertens. 9: 729-736.
129. Iwama, Y., Kato, T., Muramatsu, M., Asano, H., Shimizu, K., Toki, Y., Miyazaki, Y., Okumura, K., Hahimoto, H. and Ito, T. (1992) Correlation with blood pressure of the acetylcholineinduced endothelium-derived contracting factor in the rat aorta. Hypertension 19: 326-332.
130. Jacobs, M., Plane, F. and Bruckdorfer, K. R. (1990) Native and oxidized low density lipoproteins have different inhibitory effects on endothelium derived relaxing factor in the rabbit aorta. Br. J. Pharmacol. 100: 21-26.
131. Jaffe, E. A. (1985) Physiologic functions of normal endothelial cells. Ann. NY Acad. Sci. 454: 279-291.
132. Johns, A., Lategan, T. W., Lodge, N. J., Ryan, U. S., Van Breemen, C. and Adams, D. J. ( 1987) Calcium entry through receptoroperated channels in bovine pulmonary artery endothelial cells. Tissue Cell 19: 733-745.
133. G-nitro-L-arginine, and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta. Biochem. Biophys. Res. Commun. 199: 147-154.
134. Jovanović, A., Grbović, L. and Tulić, I. (1994) L-Arginine induces relaxation of human uterine artery with both intact and denuded endothelium. Eur. J. Pharmacol. 256: 103-107.
135. Julius, S. (1988) The therapeutic dilemma of hypertension in the elderly. Drugs 36: 7-17.
136. Kamata, K., Miyata, N., Abiru, T. and Kasuya, Y. (1992) Functional changes in vascular smooth muscle and endothelium of arteries during diabetes mellitus. Life Sci. 50: 1379-1387.
137. Kanagy, N. L, Sarkar, R., Watts, S. W. and Webb, R. C. (1996) Non-cGMP, paracrine effects of nitric oxide in the vasculature. In: Contemporary Endocrinology: Endocrinology of the Vasculature, pp. 37-47, Sowers, J. R. (ed.) Humana Press, Totoway, NJ.
138. Kanner, J., Harel, S. and Granit, R. (1991 ) Nitric oxide as an antioxidant. Arch. Biochem. Biophys. 289: 130-136.
139. Karczewski, P., Keim, M., Hartmann, M. and Schrader, J. (1992) Role of phospholamban in NO/EDRF-induced relaxation in rat aorta. Life Sci. 51: 1205-1210.
140. Katusic, Z. S. (1996) Superoxide anion and endothelial regulation of arterial tone. Free Radical Biol. Med. 20: 443-448.
141. Katusic, Z. S. and Vanhoutte, P. M. (1989) Superoxide anion is an endoirhelium-derived contracting factor. Am. J. Physiol. 257: H33-H37.
142. Kauser, K. and Rubanyi, G. M. (1995) Gender difference in endothelial dysfunction in the aorta of spontaneously hypertensive rats. Hypertension 25 (Part 1): 517-523.
143. Kazanietz, M. G. and Enero, M. A. (1991) Decreased β-adrenoceptor-mediated vasodilation in aortae from aged rats: possible involvement of a stimulatory GTP-binding protein. Eur. J. Pharmacol. 198: 177-181.
144. Keaney, J. F., Jr., Gaziano, J. M., Xu, A., Frei, B., Curran-Calentano, J., Shwaery, G. T., Loscalzo, J. and Vita, J. A. (1994a) Low-dose a-tocopherol improves and high-dose α-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbit. J. Clin. Invest. 93: 844-851.
145. Keaney, J. F., Jr., Shwaery, G. T., Xu, A., Nicolosi, R. J., Loscalzo, J., Foxall, T. L. and Vita, J. A. ( 1994b) 17-β-Estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation 89: 2251-2259.
146. G-nitro-L-arginine methyl ester. Br. J. Pharmacol. 116: 2771-2777.
147. Kerwin, J. F., Jr., Lancaster, J. R., Jr. and Feldman, P. L. (1995) Nitric oxide: a new paradigm for second messengers. J. Med. Chem. 38: 4343-4362.
148. G-Methyl-L-arginine, an inhibitor of nitric-oxide formation, reverses IL-2-mediated hypotension in dogs. J. Appl. Physiol. 76: 1130-1137.
149. Kirchner, K. A., Scanlon, P. H., Dzielak, D. J. and Hester, R. L (1993) Endothelium-derived relaxing factor responses in DOCA-salt hypertensive rats. Am. J. Physiol. 265: R568-R572.
150. Kitazono, T., Faraci, F. M., Taguchi, H. and Heistad, D. D. (1995) Role of potassium channels in cerebral blood vessels. Stroke 26: 1713-1723.
151. Knowles, R. G. and Moncada, S. (1994) Nitric oxide synthases in mammals. Biochem. J. 298: 249-258.
152. Knowles, R. G., Palacios, M., Palmer, R. M. J. and Moncada, S. (1989) Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci. USA 86: 5159-5162.
153. Knowles, R. G., Merrett, M., Salter, M. and Moncada, S. (1990a) Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat. Biochem. J. 270: 833-836.
154. Knowles, R. G., Salter, M., Brooks, S. L. and Moncada, S. (1990b) Antiinflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in lung, liver and aorta of the rat. Biochem. Biophys. Res. Commun. 172: 1042-1048.
155. Kobzik, L., Bredt, D. S., Lowenstein, C. J., Drazen, J., Gaston, B., Sugarbaker, D. and Stamler, J. S. (1993) Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am. J. Respir. Cell Mol. Biol. 9: 371-377.
156. ω-hydroxy-L-arginine to citrulline and nitric oxide. J. Biol. Chem. 296: 17776-17779.
157. Kugiyama, K., Kerns, S. A., Morrisett, J. D., Roberts, R. and Henry, P. D. (1990) Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 334: 160-162.
158. Kugiyama, K., Ohgushi, M., Sugiyama, S., Murohara, T., Fukunaga, K., Miyamoto, E. and Yasue, H. (1992) Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation. Circ. Res. 71: 1422-1428.
159. Kume, N., Cybulsky, M. I. and Gimbrone, M. A., Jr. (1992) Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cell. J. Clin. Invest. 90: 1138-1144.
160. Lamas, S., Marsden, P. A., Li, G. K., Tempst, P. and Michel, T. (1992) Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc. Natl. Acad. Sci. USA 89: 6348-6352.
161. Lamping, K. G. and Dole, W. P. (1987) Acute hypertension selectively potentiates constrictor responses of large coronary arteries to serotonin by altering endothelial function in vivo. Circ. Res. 61: 904-913.
162. Lee, T. J., Shirasaki, Y. and Nickols, G. A. (1987) Altered endothelial modulation of vascular tone in aging and hypertension. Blood Vessels 24: 132-136.
163. Lefer, A. M. and Ma, X. L. (1993) Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium. Arterioscler. Thromb. 13:771-776.
164. Leone, A. M., Palmer, R. M. J., Knowles, R. G., Francis, P. L., Ashton, D. S. and Moncada, S. (1991) Constitutive and inducible nitric oxide synthases incorporate molecular oxygen into both nitric oxide and citrulline. J. Biol. Chem. 266: 23790-23795.
165. Lewis, M. J. and Henderson, A. H. ( 1987) A phorbol ester inhibits the release of endothelium-derived relaxing factor. Eur. J. Pharmacol. 137: 167-171.
166. Lin, L., Mistry, M., Stier, C. T. and Nasjletti, A. (1991) Role of prostanoids in renin-dependent and renin-independent hypertension. Hypertension 17: 517-525.
167. 2-mediated mechanism of vascular contraction in hypertensive rats. Circ. Res. 74: 197-205.
168. Lincoln, T. M. (1983) Effects of nitroprusside and 8-bromocyclic GMP on the contractile activity of the rat aorta. J. Pharmacol. ExP. Ther. 224: 100-107.
169. Lincoln, T. (1989) Cyclic GMP and mechanisms of vasodilation. Pharmacol. Ther. 41: 479-502.
170. Lockette, W., Otsuka, Y. and Carretero, O. (1986) The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension 8 (Suppl. II): II61-II66.
171. Long, C. J. and Stone, T. W. (1985) The release of endothelium-dependent relaxant factor is calcium dependent. Blood Vessels 22: 205-208.
172. 2, and ADP. Circulation 79: 698-705.
173. Lüscher, T. F. (1990) Imbalance of endothelium-derived relaxing and contracting factors: a new concept in hypertension. Am. J. Hypertens. 3: 317-330.
174. Lüscher, T. F. (1994a) The endothelium in hypertension: bystander, target or mediator? J. Hypertens. 12 (Suppl. 10): S105-S116.
175. Lüscher, T. F. (1994b) The endothelium and cardiovascular disease: a complex relation. N. Engl. J. Med. 330: 1081-1083.
176. Lüscher, T. F. and Dubey, R. K. (1995) Endothelium and plateletderived vasoactive substances: role in the regulation of vascular tone and growth. In: Hypertension, Pathophysiology, Diagnosis and Management, 2nd edn., pp. 609-630, Larag, J. H. and Brenner, B. M. (eds.) Raven Press, New York.
177. Lüscher, T. F. and Haefeli, W. E. (1993) The L-arginine pathway in the clinical arena: tool or remedy? Circulation 87: 1746-1748.
178. Lüscher, T. F., Romern, J. C. and Vanhoutte, P. M (1986) Biossay of endothelium-derived vasoactive substances in the aorta of normorcnsive and spontaneously hypertensive rat. J. Hypertens. 4 (Suppl. 6): 81-83.
179. Lüscher, T. F., Vanhoutte, P. M. and Raij, L. (1987) Antihypertensive treatment normalizes endothelium-dependent relaxation in rats with salt-induced hypertension. Hypertension 9 (Suppl. III): III-193-III-197.
180. Lüscher, T. F., Diederich, D., Weber, E., Vanhoutte, P. M. and Bühler, F. R. (1988) Endothelium-dependent responses in carotid arteries of normotensive and hypertensive rats. Hypertension 11: 573-578.
181. Lyons, C. R., Orloff, G. J. and Cunningham, J. M. (1992) Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J. Biol. Chem. 267: 6370-6374.
182. Marín, J. (1993) Mechanisms involved in the increased vascular resistance in hypertension. J. Auton. Pharmacol. 13: 127-176.
183. Marín, J. (1995) Age-related changes in vascular responses: a review. Mech. Ageing Dev. 79: 71-114.
184. Marin, J. and Rodríguez-Martínez, M. A. (1995) Nitric oxide, oxygen-derived free radicals and vascular endothelium. J. Auton. Phannacol. 15: 279-307.
185. Marín, J. and Sánchez-Ferrer, C. F. (1990) Role of endotheliumfonned nitric oxide on vascular responses. Gen. Phatmacol. 21: 575-587.
186. Marietta, M. A. (1993) Nitric oxide synthase structure and mechanism, j. Biol. Chem. 268: 12231-12234.
187. Marietta, M. A., Yoon, P. S., Iyengar, R., Leaf, C. D. and Wishnok, J. S. (1988) Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 27: 8706-8711.
188. Marsden, P. A., Schappert, K. T., Chen, H. S., Flowers, M., Sundell, C. L., Wilcox, J. N., Lamas, S. and Michel, T. (1992) Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett. 307: 287-293.
189. Marsden, P. A., Heng, H. H., Schcrer, S. W., Stewart, R. J., Hall, A. V., Shi, X. M., Tsui, L. C. and Schappert, K. T. (1993) Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J. Biol. Chem. 268: 17478-17488.
190. Martin, W., Smith, J. A. and White, D. G. (1986) The mechanism by which haemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilators, nitric oxide or bovine retractor penis inhibitory factor. Br. J. Pharmacol. 89: 563-571.
191. Mayer, J. M., John, M, Heinzel, B., Werner, E. R., Wacher, H., Schultz, G. and Böhme, E. (1991) Brain nitric oxide synthase is a biopterin-and flavin-containing multi-functional oxido-reductase. FEBS Lett. 288: 187-191.
192. McCall, T. and Vallance, P. (1992) Nitric oxide takes centrestage with newly defined roles. Trends Pharmacol. Sci. 13: 1-6.
193. McCall, T. B., Boughton-Smith, N. K. and Palmer, R. M. J. (1989) Synthesis of nitric oxide from L-arginine by neutrophils. Biochem.J. 261: 293-296.
194. McVeigh, G. E., Brennan, G. M., Johnston, G. D., McDermott, B. J., McGrath, L. T., Henry, W. R., Andrews, J. W. and Hayes, J. R. (1992) Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35: 771-776.
195. Mellion, B. T., Ignarro, J. L, Ohlstein, E. H., Pontecorvo, E. G., Hyman, A. L. and Kadowitz, P. J. (1981) Evidence for inhibitory role of guanosine 3'-5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57: 946-955.
196. Minamiyama, Y., Takemura, S. and Inoue, M. (1996) Albumin is an important vascular tonus regulator as a reservoir of nitric oxide. Biochem. Biophys. Res. Commun. 225: 112-115.
197. Minor, R. L., Myers, P. R., Guerra, R. J., Bates, J. N. and Harrison, D. G. (1990) Diet-induced atherosclerosis increases the release of nitrogen oxide from rabbit aorta. J. Clin. Invest. 86: 2109-2116.
198. Minuz, P., Barrow, S., Cockroft, J. R. and Ritter, J. M. (1990) Prostacyclin and thromboxane biosynthesis in mild essential hypertension. Hypertension 15: 469-474.
199. Mistry, M. and Nasjletti, A. (1988) Role of pressor prostanoids in rats with angiotensin II-salt-induced hypertension. Hypertension 11: 758-762.
200. Mitsuhata, H., Shimizu, R. and Yokoyama, M. (1995) Role of nitric oxide in anaphylactic shock. J. Clin. Immunol. 15: 277-283.
201. Mittal, C. K. (1993) Nitric oxide synthase: involvement of oxygen radicals in conversion of L-arginine to nitric oxide. Biochem. Biophys. Res. Commun. 193: 126-132.
202. Mohaupt, M. G., Elzie, J. L., Ahn, K. Y., Clapp, W. L., Wilcox, C. S. and Kone, B. C. (1994) Differential expression and induction of mRNAs encoding two inducible nitric oxide synthases in rat kidney. Kidney Int. 46: 653-665.
203. Moncada, S. (1994) Nitric oxide. J. Hypertens. 12 (Suppl. 10): S35-S39.
204. Moncada, S. and Higgs, E. A. (1995) Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 9: 1319-1330.
205. Moncada, S., Palmer, R. M. and Higgs, E. A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-142.
206. Moncada, S., Higgs, E. A. and Furchgott, R. (1997) International Union of Pharmacology nomenclature in nitric oxide research. Pharmacol. Rev. 49:137-142.
207. 2+ dynamics in endothelial cells. Am. J. Physiol. 253: C588-C598.
208. Moro, M. A., Darley-Usmar, V. M., Goodwin, D. A., Read, N. G., Zamora-Pino, R., Feelisch, M., Radowski, M. W. and Moncada, S. ( 1994) Paradoxical fate and biological action of peroxynitrite on human platelets. Proc. Natl. Acad. Sci. USA 91: 6702-6706.
209. Nahir, A. M., Shapira, D. and Scharf, Y. (1986) Double-blind randomized trial of nitroderm TTS in the treatment of Raynaud's phenomenon. Isr. J. Med. Sci. 22: 139-142.
210. Nakaki, T. and Kato, R. (1994) Beneficial circulatory effect of L-arginine. Jpn. J. Pharmacol. 66: 167-171.
211. Nakaki, T., Nakayama, M. and Kato, R. (1990a) Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur. J. Pharmacol. 189: 347-353.
212. 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells. Mol. Pharmacol. 37: 30-36.
213. G-monomethyl L-arginine on endothelium-dependent relaxation in arterioles of one-kidney, one clip hypertensive rats. Hypertension 17: 875-880.
214. Nakane, M., Mitchell, J., Förstermann, U. and Murad, F. (1991) Phosphorylation by calcium calmodulin-dependent protein kinase II and protein kinase C vasodilation in patients with to oxide synthase. Biochem. Biophys. Res. Commun. 180: 1396-1402.
215. Nakane, M., Schmidt, H. H., Pollock, J. S., Forstermann, U. and Murad, F. (1993) Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett. 316: 175-180.
216. Nakatsu, K. and Diamond, J. (1989) Role of cGMP in relaxation of vascular and other smooth muscle. Can. J. Physiol. Pharmacol. 67: 251-262.
217. Nathan, C. F. and Hibbs, J. B. (1991) Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3: 65-70.
218. Nathan, C. and Xie, Q. (1994) Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269: 13725-13728.
219. Nelson, M. T. and Quayle, J. M. (1995) Physiological roles and properties of potassium channels in arterial smooth muscle. Am. J. Physiol. 268: C799-C822.
220. Nielsen, H., Hasenkam, J. M., Pilegaard, H. K., Aalkjaer, C. and Mortensen, F. V. (1992) Age-dependent changes in α-adrenoceptor mediated contractility of isolated human resistance arteries. Am. J. Physiol. 263: H1190-H1196.
221. Nishida, K., Harrison, D. G., Navas, J. P., Fisher, A. A., Dockery, S. P., Uematsu, M., Nerem, R. M., Alexander, R. W. and Murphy, T. J. ( 1992) Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J. Clin. Invest. 90: 2092-2096.
222. Noeh, F. M., Wenzel, A., Harris, K, Milakofsky, L., Hofford, J. M., Pell, S. and Vogel, W. H. (1996) The effects of arginine administration on the levels of arginine, other amino acids and related amino compounds in the plasma, heart, aorta, vena cava, bronchi and pancreas of the rat. Life Sci. 58: 131-138.
223. Ohara, Y., Peterson, T. E. and Harrison, D. G. (1993) Hypercholesteirolemia increases endothelial Superoxide anion production. J.Clin. Invest. 91: 2546-2551.
224. Oishi, K., Raynor, R. L., Charp, P. A. and Kuo, J. F. (1988) Regulation of protein kinase C by lysophospholipids: potential role in signal transduction. J. Biol. Chem. 263: 6865-6871.
225. Otsuka, Y., Dipiero, A., Hirt, E., Brennaman, B. and Lockette, W. (1988) Vascular relaxation and cGMP in hypertension. Am. J. Physiol. 254: H163-H169.
226. Palacios, M., Knowles, R. G., Palmer, R. M. and Moncada, S. (1989) Nitric oxide from L-arginine stimulates the soluble guanylate cyclase in adrenal glands. Biochem. Biophys. Res. Commun. 165: 802-809.
227. Palmer, R. M. and Moncada, S. (1989) A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem. Biophys. Res. Commun. 158: 348-352.
228. Palmer, R. M., Ferrige, A. G. and Moncada, S. (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526.
229. Panza, J. A., Quyyumi, A. A., Brush, J. E. and Epstein, S. E. (1990) Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N. Engl. J. Med. 323: 22-27.
230. Panza, J. A., Quyyumi, A. A., Callahan, T. S. and Epstein, S. E. (1993) Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J. Am. Coll. Cardiol. 21: 1145-1151.
231. Parrillo, J. E. (1993) Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328: 1471-1477.
232. Peiró, C., De Sagarra, M. R., Redondo, J., Sánchez-Ferrer, C. F. and Marín, J. (1992) Vascular smooth muscle proliferation in hypertensive transgenic rats. J. Cardiovasc. Pharmacol. 20 (Suppl. 12): S128-S131.
233. Petros, A., Bennett, D. and Vallance, P. (1991) Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338: 1557-1558.
234. Pieper, G. M. and Peltier, B. A. (1995) Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium. J. Cardiovasc. Pharmacol. 25: 397-403.
235. Pinto, A., Sorrentino, R., Sorrentino, P., Guerritore, T., Miranda, L., Biondi, A. and Martinell, P. (1991) Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension. Am. J. Obstet. Gynecol. 164: 507-513.
236. Plane, F., Bruckdorfer, K. R., Kerr, P., Stever, A. and Jacobs, M. (1992) Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta. Br. J. Pharmacol. 105: 216-222.
237. Pollock, J. S., Föstermann, U., Mitchell, J. A., Warner, T. D., Schmidt, H. H. and Nakane, M. (1991) Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA 88: 10480-10484.
238. Pollock, J. S., Nakane, M., Buttery, L. K., Martinez, A., Springall, D., Polak, J. M., Förstermann, U. and Murad, F. (1993) Characterization and localization of endothelial nitric oxide synthase using specific monoclonal antibodies. Am. J. Physiol. 265: C1379-C1387.
239. Prince, R. C. (1993) Rising interest in nitric oxide synthase. Trends Biol. Sci. 18: 35-36.
240. Radomski, M. W., Palmer, R. M. and Moncada, S. (1987) Comparative pharmacology of endothelium derived relaxing factor, nitric oxide and prostacyclin in platelets. Br. J. Pharmacol. 92: 181-187.
241. Radomski, M. W., Palmer, R. M. and Moncada, S. (1990a) Characterization of the L-arginine/nitric oxide pathway in human platelets. Br. J. Pharmacol. 101: 325-328.
242. Radomski, M. W., Palmer, R. M. and Moncada, S. (1990b) An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. USA 87: 5193-5197.
243. Ramos, K. S. (1992) Vascular toxicology: a cellular and molecular perspective. In: Cardiovascular Toxicology, 2nd edn., pp. 483-516, Acosta, D., Jr. (ed.) Raven Press, New York.
244. Ramsey, B., De Belder, A., Campbell, S., Moncada, S. and Martin, J. F. (1994) A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of pre-eclampsia. Eur. J. Clin. Invest. 24: 76-78.
245. Rapoport, R. and Murad, F. (1983) Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP. J. Cyclic Nucleotide Protein Phosphorylation Res. 9:281-296.
246. Rapoport, R. M. and Murad, F. (1986) Cyclic AMP may produce vascular relaxation by inhibition of inositol triphosphate generation in rat aorta. Circ. Res. 61: 265-272.
247. Rapoport, R. M., Draznin, M. B. and Murad, F. (1983) Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature 306: 174-176.
248. + pump inhibitors and membrane depolarizing agents on acetylcholine-induced endothelium-dependent relaxation and cyclic GMP accumulation in rat aorta. Eur. J. Pharmacol. 110: 203-209.
249. Rapoport, R. M., Schwartz, K. and Murad, F. (1985b) Effects of sodium-potassium pump inhibitors and membrane depolarizing agents on sodium nitroprusside-induced relaxation of cyclic guanosine monophosphate accumulation in rat aorta. Circ. Res. 57: 164-170.
250. Ravichandran, L. V., Johns, R. A. and Rengasamy, A. (1995) Direct and reversible inhibition of endothelial nitric oxide synthase by nitric oxide. Am. J. Physiol. 268: H2216-H2223.
251. Rees, D. D., Palmer, R. M., Hodson, H. F. and Moncada, S. (1989a) A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br. J. Pharmacol. 96: 418-424.
252. Rees, D. D., Palmer, R. M. and Moncada, S. (1989b) Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. USA 86: 3375-3378.
253. Rees, D. D., Cellek, S., Palmer, R. M. J. and Moncada, S. (1990) Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem. Biophys. Res. Commun. 173: 541-547.
254. Regunathan, S., Youngson, C., Raasch, W. and Reis, D. J. (1995) Imidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation. J. Pharmacol. Exp. Ther. 276: 1272-1282.
255. Reis, D. J., Li, G. and Regunathan, S. (1995) Endogenous ligands of imidazoline receptors: classic and immunoreactive clonidine displacing substance (CDS) and agmatine. Ann. NY Acad. Sci. 763: 295-313.
256. ω-hydroxyarginine to citrulline and nitrogen oxides and occurrence in NO synthases of a sequence very similar to the heme-binding sequence in P450s. Biochem. Biophys. Res. Commun. 192: 53-60.
257. Richard, V., Tanner, F. C., Tschudi, M. and Lüscher, T. F. (1990) Different activation of L-arginine pathway by bradykinin, serotonin, and clonidine in coronary arteries. Am. J. Physiol. 259: H1433-H1439.
258. Robertson, B. E., Schubert, R., Hescheler, J. and Nelson, M. T. (1993) cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. Am. J. Physiol. 265: C299-C303.
259. Rodrigo, J., Springall, D. R., Uttenthal, O., Bentura, M. L., Abadía-Molino, F., Riveros-Moreno, V., Martínez-Murillo, R., Polak, J. M. and Moncada, S. (1994) Localization of nitric oxide synthase in the adult rat brain. Philos. Trans. R. Soc. Lond. B Biol. Sci. 345: 175-221.
260. Rosenkranz-Weiss, P., Sessa, W. C., Milstien, S., Kaufman, S., Watson, C. A. and Pober, J. S. (1994) Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. J. Clin. Invest. 93: 2236-2243.
261. Rubanyi, G. M. (1991) Endothelium-derived relaxing and contracting factors. J. Cell. Biochem. 46: 27-36.
262. Rubanyi, G. M. and Vanhoutte, P. M. (1986) Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle. Am. J. Physiol. 250: H815-H821.
263. Rubanyi, G. M., Lorenz, R. R. and Vanhoutte, P. M. ( 1985) Bioassay of endothelium-derived relaxing factor(s): inactivation by catecholamines. Am. J. Physiol. 249: H95-H101.
264. Rubanyi, G. M., Ho, E. L., Cantor, E. H., Lumma, W. C. and Botelho, L. H. (1991) Cytoprotective function of nitric oxide: inactivation of Superoxide radicals produced by human leucocytes. Biochem. Biophys. Res. Commun. 181: 1392-1397.
265. Saenz de Tejada, I., Goldstein, I., Azadzoi, K., Krane, R. J. and Cohen, R. A. (1989) Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N. Engl. J. Med. 320: 1025-1030.
266. Safar, M. E. (1985) Focus on the large arteries and in hypertension. J. Cardiovasc. Pharmacol. 7 (Suppl. 2): S1-S4.
267. Saffrey, M. J., Hassall, C. J., Hoyle, C. H., Belai, A., Moss, J., Schmidt, H. H., Murad, F. and Burnstock, G. (1992) Colocalization of nitric oxide synthase and NADPH-diaphorase in cultured myenteric neurones. Neuroreport 3: 333-336.
268. Salvemini, D. and Botting, R. (1990) The effects of free radical scavengers on platelet adhesion and aggregation. Drug News Perspect. 4:202-212.
269. Salvemini, D., De Nucci, G., Gryglewski, R. J. and Vane, J. R. (1989) Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor. Proc. Natl. Acad. Sci. USA 86: 6328-6332.
270. Sánchez-Ferrer, C. F. and Marín, J. (1990) Endothelium-derived contractile factors. Gen. Pharmacol. 21: 589-603.
271. 45Ca in rat isolated aorta. Naunyn-Schmiedebergs Arch. Pharmacol. 336: 287-294.
272. Schmidt, H. H. (1992) -NO, CO and -OH endogenous soluble guanylyl cyclase-activating factors. FEBS Lett. 307: 102-107.
273. Schmidt, H. H., Wilke, P., Evers, B. and Bohme, E. (1989) Enzymatic formation of nitrogen oxides from L-arginine in bovine brain cytosol. Biochem. Biophys. Res. Commun. 165: 284-291.
274. Schmidt, H. H., Gagne, G. D., Nakane, M., Pollock, J. S., Miller, M. F. and Murad, F. (1992a) Mapping of neural nitric oxide synthase in the rat suggests frequent co-localization with NADPH-diaphorase but not with soluble guanylyl cyclase, and novel paraneural functions for nitrinergic signal transduction. J. Histochem. Cytochem. 40: 1439-1456.
275. Schmidt, H. H., Warner, T. D., Ishii, K., Sheng, H. and Murad, F. (1992b) Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides. Science 255: 721-723.
276. Schoedon, G., Schneemann, M., Walter, R., Blau, N., Hofer, S. and Schaffner, A. (1995) Nitric oxide and infection: another view. Clin. Infect. Dis. 21 (Suppl. 2): S152-S157.
277. G'-hydroxy-L-arginine causes nitrite production in vascular smooth muscle cells in the absence of nitric oxide synthase activity. FEBS Lett. 341: 203-207.
278. Schulz, R., Nava, E. and Moncada, S. (1992) Induction and potential biological relevance of a calcium-independent nitric oxide synthase in the myocardium. Br. J. Pharmacol. 105: 575-580.
279. Scott-Burden, T., Schini, V. B., Elizondo, E., Junquero, D. C. and Vanhoutte, P. M. (1992) Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells: effects on cell proliferation. Circ. Res. 71: 1088-1100.
280. Sellke, F. W., Armstrong, M. L. and Harrison, D. G. (1990) Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation 81: 1586-1593.
281. Sessa, W. C. (1994) The nitric oxide synthase family of proteins. J. Vasc. Res. 31: 131-143.
282. Sessa, W. C., Harrison, J. K., Barber, C. M., Zeng, D., Durieux, M. E., D'Angelo, D. D., Lynch, K. R. and Peach, M. J. (1992) Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J. Biol. Chem. 267: 15274-15276.
283. Shaw, A. and Vosper, A. J. (1977) Solubility of nitric oxide in aqueous and nonaqueous solvents. J. Chem. Soc. Faraday Trans. 8: 1239-1244.
284. Sheng, H., Schmidt, H. H., Nakane, M., Mitchell, J. A., Pollock, J. S., Förstermann, U. and Murad, F. (1992) Characterization and localization of nitric oxide synthase in non-adrenergic non-cholinergic nerves from bovine retractor penis muscles. Br. J. Pharmacol. 106: 768-773.
285. Sheng, H., Gagne, G. D., Matsumoto, T., Miller, M. F., Förstermann, U. and Murad, F. (1993) Nitric oxide synthase in bovine superior cervical ganglion. J. Neurochem. 61: 1120-1126.
286. Shepherd, J. T. (1990) Increased systemic vascular resistance and primary hypertension: the expanding complexity. J. Hypertens. 8(Suppl. 7): S15-S27.
287. Shichiri, M., Hirata, Y., Ando, K., Emori, T., Ohta, K., Kimoto, S., Ogura, M., Inoue, A. and Marumo, F. (1990) Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 15: 493-496.
288. Shimamura, K., Osugi, S., Moriyama, K. and Sunano, S. (1991) Impairment and protection of endothelium-dependent relaxation in aortae of various strains of spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 17 (Suppl. 3): S133-S136.
289. 2 as an endothelium-derived contracting factor in diabetic state. Diabetes 42: 1246-1252.
290. Shimokawa, H. and Vanhoutte, P. M. (1989) Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis. Circ. Res. 64: 900-914.
291. 2)-like substance. Life Sci. 42: 437-445.
292. Shirasaki, Y., Kolm, P., Nickols, A. and Lee, T. J.-F. (1988) Endothelial regulation of cyclic GMP and vascular responses in hypertension. J. Pharmacol. Exp. Ther 245: 53-58.
293. Simionescu, M. and Simionescu, N. (1986) Functions of endothelial cell surface. Annu. Rev. Physiol. 48: 279-293.
294. Simon, B. C., Cunningham, L. D. and Cohen, R. A. (1990) Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the big coronary artery. J. Clin. Invest. 86: 75-79.
295. Simon, B. C., Haudenschild, C. C. and Cohen, R. A. (1993) Preservation of endothelium-dependent relaxation in atherosclerotic rabbit aorta by probucol. J. Cardiovasc. Pharmacol. 21: 893-901.
296. + exchange, c-fos expression and mitogenesis in rat mesangial cells. J. Clin. Invest. 83: 708-712.
297. Smith, W. M. (1988) Epidemiology of hypertension in older patients. Am. J. Med. 38 (Suppl. 3B): 2-6.
298. Stamler, J. S., Jaraki, O., Osborne, J., Simon, D. I., Keaney, J., Vita, J., Singel, D., Valeri, C. R. and Loscalzo, J. (1992) Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. USA 89: 7674-7677.
299. Steinberg, D. and Witztum, J. L. (1990) Antioxidants and atherosclerosis. JAMA 264: 3047-3052.
300. Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C. and Witztum, J. L. (1989) Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-924.
301. Struyker-Boudier, H. A., Van Bortel, L. M. and Demey, J. G. (1990) Remodeling of the vascular tree in hypertension: drug effects. Trends Pharmacol. Sci. 11: 240-245.
302. Stuehr, D. J., Cho, H. J., Kwon, N. S., Weise, M. F. and Nathan, C. F. (1991) Purification and characterizacion of the cytokineinduced macrophage nitric oxide synthase. Proc. Katl. Acad. Sci. USA 88: 7773-7777.
303. Suzuki, N., Miyauchi, T., Tomobe, Y., Matsumoto, H., Goto, K., Masaki, T. and Fujino, M. (1990) Plasma concentrations of endothelin-1 in spontaneously hypertensive rats and DOCA-salt hypertensive rats. Biochem. Biophys. Res. Commun. 167: 941-947.
304. Takase, H., Moreau, P., Küng, C. F., Nava, E. and Lüscher, T. F. (1996) Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency: effect of verapamil and trandolapril. Hypertension 27: 25-31.
305. Tanase, H. (1979) Genetic control of blood pressure in spontaneously hypertensive rats (SHR). Exp. Anim. (Tokyo) 28: 519-530.
306. + channels are stimulated by cyclic guanosine monophosphate-dependent protein kinase in canine coronary artery smooth muscle cells. Pflügers Arch. 423: 167-172.
307. Tesfamariam, B. and Cohen, R. A. (1992) Free radical mediate endothelial cell dysfunction caused by elevated glucose. Am. J. Physiol. 90: 727-732.
308. 2. Am. J. Physiol. 257: H1327-H1333.
309. Tesfamariam, B., Brown, M. L. and Cohen, R. A. (1991) Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J. Clin. Invest. 87: 1643-1648.
310. + pump activity in diabetic rabbit carotid artery: reversal by aldose reductase inhibition. Am. J. Physiol. 34: 1194-1198.
311. Thomsen, L. L., Iversen, H. K., Lassen, L. H. and Olesen, J. (1994) The role of nitric oxide in migraine pain. CNS Drugs 2: 417-422.
312. Togashi, H., Sakuma, I., Yoshioka, M., Kobayashi. T., Yasuda, H., Kitabatake, A., Saito, H., Gross, S. S. and Levi, R. (1992) A central nervous system action of nitric oxide in blood pressure regulation. J. Pharmacol. Exp. Ther. 262: 343-347.
313. Tsai, A. ( 1994) How does NO activate hemoproteins.' FEBS Lett. 341: 141-145.
314. Tschudi, M. R., Criscione, L. and Lüscher, T. F. (1991) Effect of aging and hypertension on endothelial function of rat coronary arteries.J. Hypertens. 9 (Suppl. 6): 164-165.
315. Tschudi, M. R., Mesaros, S., Lüscher. T. F. and Malinski, T. (1996) Direct in situ measurement of nitric oxide in mesenteric resistance arteries: increased decomposition by Superoxide in hypertension. Hypertension 27: 32-35.
316. Vallance, P., Collier, J. and Moncada, S. (1989) Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet ii: 997-1004.
317. Vallance, P., Leone, A., Calver, A., Collier, J. and Moncada, S. (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339: 572-575.
318. Van de Voorde, J. and Leusen, I. (1986) Endothelium dependent and independent relaxation of aortic rings from hypertensive rats. Am. J. Physiol. 250: H711-H717.
319. Van de Voorde, J., Vanheel, B. and Leusen, I. ( 1988) Depressed endothelium-dependent relaxation in hypertension: relation to increased blood pressure and reversibility. Pflugers Arch. 411: 500-504.
320. Vane, J. R., Änggård, E. E. and Botting, R. M. (1990) Regulatory functions of the vascular endothelium. N. Engl. J. Med. 323: 27-36.
321. Vanhoutte, P. M. and Shimokawa, H. (1989) Endothelium-derived relaxing factor and coronary vasospasm. Circulation 80: 1-9.
322. Vanhoutte, P. M, Rubanyi, G. M., Miller, V. M. and Houston, D. S. (1986) Modulation of vascular smooth muscle contraction by the endothelium. Annu. Rev. Physiol. 48: 307-320.
323. Vasalle, M. (1987) Contribution of the Na,K-pump to the membrane potential. Experientia 43: 1135-1140.
324. Verbeuren, T. J., Jordaens, F. H., Zonnenkeyn, L. L., Van-Hove, C. E., Coene, M. C. and Herman, A. G. (1986) Effect of hyper-cholesterolemia on vascular reactivity in the rabbit I: endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholes-terolemic rabbits. Circ. Res. 58: 552-564.
325. Verbeuren, T. J., Bonhomme, E., Laubie, M. and Simonet, S. (1993) Evidence for induction of non-endothelial NO synthase in aortas of cholesterol-fed rabbits. J. Cardiovasc. Pharmacol. 21: 841-845.
326. Vincent, M., Kaiser, M. A., Orea, V., Lodwick, D. and Samani, N.J. (1994) Hypertension in the spontaneously hypertensive rat and sex chromosomes. Hypertension 23: 161-166.
327. Vodovotz, Y., Kwon, N. S., Pospischil, M., Manning, J., Paik, J. and Nathan, C. (1994) Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-γ and bacterial lipopolysaccharide. J. Immunol. 152: 4110-4118.
328. Vokonas, P. S., Kannel, W. B. and Cupples, L. A. (1988) Epidemiology and risk of hypertension in the elderly: the Framingham study. J. Hypertens. 6 (Suppl. 1 ): S3-S9.
329. Wadsworth, R. M. (1990) Calcium and vascular reactivity in ageing and hypertension. J. Hypertens. 8: 975-983.
330. Waldman, S. A. and Murad, F. (1987) Cyclic GMP synthesis and function. Pharmacol. Rev. 39: 163-196.
331. Wang, P., Ba, Z. F. and Chaudry, I. H. (1994) Nitric oxide: to block or enhance its production during sepsis? Arch. Surg. 129: 1137-1143.
332. Wei, X.-Q., Charles, I. G., Smith, A., Ure, J., Feng, G.-J., Huang, F.-P., Xu, D., Muller, W., Moncada, S. and Liew, F. Y. (1995) Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375: 408-411.
333. Weiner, C. P., Lizasoain, I., Baylis, S. A., Knowles, R. G., Charles, I. G. and Moncada, S. (1994) Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc. Natl. Acad. Sci. USA 91: 5212-5216.
334. Weisbrod, R. M., Brown, M. L and Cohen, R. A. (1993) Effect of elevated glucose on cyclic GMP and eicosanoids produced by porcine aortic endothelium. Artherioscler. Thromb. 13: 915-923.
335. Welch, G. and Loscalzo, J. (1994) Nitric oxide and the cardiovascular system. J. Cardiovasc. Surg. 9: 361-371.
336. Werner, E. R., Werner-Felmayer, G. and Wachter, H. (1993) Tet-rahydrobiopterin and cytokines. Proc. Soc. Exp. Biol. Med. 203: 1-12.
337. White, A. K. and Marietta, M. A. (1992) Nitric oxide synthase is a cytochrome P-450 type hemoproteine. Biochemistry 31: 6627-6631.
338. Williams, S. P., Shackelford, D. P., Iams, S. G. and Mustafa, S. (1988) Endothelium-dependent relaxation in estrogen-treated spontaneously hypertensive rats. Eur. J. Pharmacol. 145: 205-207.
339. Winlaw, D. S., Smythe, G. A., Keogh, A. M., Schyvens, C. G., Spratt, P. M. and Macdonald, P. S. (1994) Increase nitric oxide production in heart failure. Lancet 344: 373-374.
340. Wolff, S. P. and Dean, R. T. (1987) Glucose autoxidation and protein modification: the role of oxidative glucosylation in diabetes. Biochem. J. 245: 234-250.
341. Wood, K. S., Buga, G. M., Byrns, R. E. and Ignarro, L. J. (1990) Vascular smooth muscle-derived relaxing factor (MDRF) and its close similarity to nitric oxide. Biochem. Biophys. Res. Commun. 170: 80-88.
342. Wright, C. D., Mulsch, A., Busse, R. and Osswald, H. (1989) Generation of nitric oxide by human neutrophils. Biochem. Biophys. Res. Commun. 160: 813-819.
343. Wright, C. E. and Angus, J. A. (1986) Effects of hypertension and hypercholesterolemia on vasodilation in the rabbit. Hypertension 8: 361-371.
344. Wu, K. K. and Thiagarahan, P. (1996) Role of endothelium in thrombosis and hemostasis. Annu. Rev. Med. 47: 315-331.
345. Xie, Q. W., Cho, H. J., Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., Dinig, A., Troso, T. and Nathan, C. (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256: 225-228.
346. Xu, W., Charles, I., Moncada, S., Gorman, P., Liu, L. and Emson, P. (1993a) Chromosomal assignment of the inducible NOS gene and endothelial NOS gene to human chromosome 17p 11-17q 11 and chromosome 7, respectively. Endothelium 1: S24.
347. Xu, W., Gorman, P., Sheer, D., Bates, G., Kishimoto, J., Lizhi, L. and Emson, P. (1993b) Regional localization of the gene coding for human brain nitric oxide synthase (NOS1) to 12q 24.2→24.31 by fluorescent in situ hybridization. Cytogenet. Cell Genet. 64: 62-63.
348. Yagi, K. and Komura, S. (1986) Inhibitory effect of female hormones on lipid peroxidation. Biochem. Int. 13: 1051-1055.
349. Yang, S.-T., Mayhan, W. G., Furaci, F. M. and Heistad, D. D. (1991) Endothelium-dependent responses of cerebral blood vessels during chronic hypertension. Hypertension 17: 612-618.